A cardiologist in Billings, Montana, says her new-look practice was designed to reach patients faster and ditch unnecessary red tape. Patients pay an upfront fee, and insurance does not play a role in treatment decisions.

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value. 

Cardiology's gains are far less than some specialties—pay for dermatologists went up more than 10%, for instance—but still ahead of the consumer price index.

Professor Om Shankar, who lost his hospital leadership position as a result of the strike, is now forming a committee with like-minded protesters to “spread the agitation all across the country.”

The deal, first announced in April, has been finalized. Shockwave will now operate as a business unit within Johnson & Johnson MedTech, and its common stock is no longer trading on NASDAQ.

Heuser had a long, impactful career in cardiology. One former colleague said he was “an amazing interventional cardiologist and an even better human being.”

"When you think about the rise of amputations in a country like the United States, that's concerning because it should not be happening here," one interventional cardiologist said. 

Researchers examined data from eight different studies, noting that transcaval TAVR appears to be a "viable alternative" when transfemoral access is not an option. The procedure was linked to an overall success rate of 98.5%.